| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/11/2009 | EP2021370A1 Trail receptor-binding agents and uses of the same |
| 02/11/2009 | EP2021356A2 Hiv vaccine |
| 02/11/2009 | EP2021033A2 Il-1 immunization induces autoantibodies protective against atherosclerosis |
| 02/11/2009 | EP2021030A2 Buffering agents for biopharmaceutical formulations |
| 02/11/2009 | EP2021029A2 Humanized fc riib-specific antibodies and methods of use thereof |
| 02/11/2009 | EP2021028A2 Methods and compositions for modulation of blood-neural barrier |
| 02/11/2009 | EP2021027A2 Immunoglobulin associated cell-surface determinants in the treatment of b-cell disorders |
| 02/11/2009 | EP2021026A1 Use of il-i antibodies for treating ophthalmic disorders |
| 02/11/2009 | EP2021025A1 Method and means for treating inflammatory bowel disease |
| 02/11/2009 | EP2021024A1 Nicotine-carrier vaccine formulation |
| 02/11/2009 | EP2021023A2 Myxoma virus mutants for cancer treatment |
| 02/11/2009 | EP2021022A2 Apparatus, methods and systems for toxin delivery to the nasal cavity |
| 02/11/2009 | EP2021021A2 Anthrax compositions and methods of use and production |
| 02/11/2009 | EP2021020A2 Secreted campylobacter flagella coregulated proteins as immunogens |
| 02/11/2009 | EP2021018A2 Rapid detection of mycobacterium tuberculosis and antimicrobial drug resistance |
| 02/11/2009 | EP2021017A2 Method |
| 02/11/2009 | EP1748792B1 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same |
| 02/11/2009 | EP1747262A4 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 02/11/2009 | EP1487484B1 Use of mixtures of lipopeptides for vaccine production |
| 02/11/2009 | EP1429800B1 Vaccine and use thereof for treatment of amyotrophic lateral sclerosis |
| 02/11/2009 | EP1409012B1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 02/11/2009 | EP1309334B1 Combination therapy using reovirus and anti-antireovirus antibodies for the treatment of ras-mediated proliferative disorders |
| 02/11/2009 | EP1259258B1 Gm-negative ehv-mutants |
| 02/11/2009 | EP1140164B1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 02/11/2009 | EP1109577B1 Multicomponent vaccines against Staphylococcus aureus |
| 02/11/2009 | EP0954286B1 Liposomal influenza vaccine composition and method |
| 02/11/2009 | EP0946731B1 Non-m non-o hiv strains, fragments and applications |
| 02/11/2009 | EP0879244B1 Mycoplasma recombinant polypeptide and vaccines |
| 02/11/2009 | EP0784059B1 Polynucleotides encoding an antigenic polypeptide of chlamydia pneumoniae |
| 02/11/2009 | CN101365799A Method for preparing antibodies selective for activating Fc receptors |
| 02/11/2009 | CN101365723A Antibodies directed to her-3 and uses thereof |
| 02/11/2009 | CN101365722A Methods of purifying anti a beta antibodies |
| 02/11/2009 | CN101365715A Matrix metalloproteinase 11 vaccine |
| 02/11/2009 | CN101365714A Tuberculosis antigen detection assays and vaccines |
| 02/11/2009 | CN101365713A Porcine circovirus type 2 vaccines |
| 02/11/2009 | CN101365488A A therapeutic composition comprising an inhibitor of an hsp 90 protein |
| 02/11/2009 | CN101365487A Method for treating joint damage |
| 02/11/2009 | CN101365486A Combination therapy using anti-EGFR and anti-HER2 antibodies |
| 02/11/2009 | CN101365485A Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
| 02/11/2009 | CN101365484A Immunization of avians by administration of non-replicating vectored vaccines |
| 02/11/2009 | CN101365483A Adjuvanted influenza vaccines including cytokine-inducing agents |
| 02/11/2009 | CN101365482A Canine influenza vaccines |
| 02/11/2009 | CN101365481A Canine influenza virus and related compositions and methods of use |
| 02/11/2009 | CN101365480A Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment |
| 02/11/2009 | CN101365479A Chimeric viruses presenting non-native surface proteins and uses thereof |
| 02/11/2009 | CN101362802A DNA dependent protein kinase catalytic subunit single-chain antibody and its encoding gene and application |
| 02/11/2009 | CN101362796A B cell epitope of epididymal protease inhibitor and multiple antigenic peptide containing thereof |
| 02/11/2009 | CN101362795A B cell epitope of epididymal protease inhibitor and antigen peptides containing thereof |
| 02/11/2009 | CN101362794A B cell epitope of follicle-stimulating hormone receptor and antigen peptides containing thereof |
| 02/11/2009 | CN101361973A Medicine for treating chicken pox and preparation method thereof |
| 02/11/2009 | CN101361972A Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 02/11/2009 | CN101361971A Preparation technique of Vibrio vulnificus whole-cell immunity stimulated compound vaccine and use thereof in aquatic animal |
| 02/11/2009 | CN101361755A Extraction technique of Shengmu Rutai immunological active substance and capsules production method |
| 02/11/2009 | CN101361716A Porous microspheres and use thereof in preparing porous microspheres vaccine |
| 02/11/2009 | CN100460874C Method for sieving crimp-relevant protain activator or antagonist |
| 02/11/2009 | CN100460503C Bacterin for pleuropneumonia actinobacillus serotype 1 double-gene deletion mutant without resistance marker |
| 02/11/2009 | CN100460421C Immunoglobulin variants and uses thereof |
| 02/11/2009 | CN100460019C Microparticles comprising carbohydrate beads covalently linked with allergen |
| 02/11/2009 | CN100460015C Immunological regulator and application thereof |
| 02/11/2009 | CN100460014C Helicobacter pylori vaccine based on urease B subunit active segment and prepn process thereof |
| 02/11/2009 | CN100460013C Oral administration recombinant helicobacterpylori vaccine and preparing method thereof |
| 02/10/2009 | US7488814 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 02/10/2009 | US7488808 Janus family kinases and identification of immune modulators |
| 02/10/2009 | US7488803 Anticancer agents; two primordial germ cell-specific expressed genes, Fragilis and Stella; as markers for primordial germ cells |
| 02/10/2009 | US7488802 agonists and/or antagonists of PD-1 (Programmed Death 1) thereby modulate immune responses; treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer |
| 02/10/2009 | US7488800 Isolated water soluble VP1 polypeptide of foot and mouth viral disease; containing sequence number 3; cancer, reperfusion injuries; neurodegenerative, autoimmune and immunodeficiency diseases; activating procaspase 9, 7 or 3 |
| 02/10/2009 | US7488793 Isolated peptide which binds to HLA-Cw*07 and uses thereof |
| 02/10/2009 | US7488792 Peptides; antitumor agents; anticancer agents |
| 02/10/2009 | US7488791 capable of stimulating the production of anti-HPV T CD4+ lymphocytes for vaccination against uterine of uterus cancer or as diagnostic reagent of HPV-specific T lymphocytes, in particular for assessing the immune condition of patients |
| 02/10/2009 | US7488717 Methods of inhibiting chemokine binding to chemokine receptors |
| 02/10/2009 | US7488491 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/10/2009 | US7488490 Synergistic mixture of oligonucleotides and antigen; induce immunology response |
| 02/10/2009 | US7488489 For inducing an immune response against Plasmodium falciparum |
| 02/10/2009 | US7488488 Polypeptide, polynucleotide, vector, transformant, antibody, vaccine, and receptor binding assay; miticide vaccines or prophylactic and preventitive vaccines for piroplasmosis, Q fever, or viral encephalitis |
| 02/10/2009 | US7488487 Administering an auxotropic attenuation strain of Listeria which expresses an antigen; induction immunology response; anticancer agents |
| 02/10/2009 | US7488486 Pharmaceutical compositions and articles of manufacture useful in reversal of a clinical epiosode of an incurable disease and methods of use thereof |
| 02/10/2009 | US7488485 Viral proteins which stimulating immunology response |
| 02/10/2009 | US7488484 Multimeric protein fo treating and preventing viral infection; immunosuppressant |
| 02/10/2009 | US7488482 Pharmaceutical compositions for treating papillomavirus tumors and infection |
| 02/10/2009 | US7488481 Polypeptides derived from anti-HIV-1 gp120 antibodies that abrogate gp120 binding to CCR5 |
| 02/10/2009 | US7488480 Administering to the egg- laying vertebrate or to an egg of the vertebrate the vaccine of immunoconjugate of myostatin polypeptide linked to a carrier to increase muscle weight |
| 02/10/2009 | US7488479 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| 02/10/2009 | US7488478 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function; chronic synovitis, autoimmune diseases, rheumatoid arthritis |
| 02/10/2009 | US7488477 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies |
| 02/10/2009 | US7488476 Peptide with amino acid sequences and biologial homologues or derivatives for vaccines or antibodies |
| 02/10/2009 | US7488475 Antibody therapy of tumors |
| 02/10/2009 | CA2344086C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 02/10/2009 | CA2339299C Method of modulating memory effector t-cells and compositions |
| 02/10/2009 | CA2331368C Nucleic acid vaccines for prevention of flavivirus infection |
| 02/10/2009 | CA2329776C Antibody against lar phosphatase subunit |
| 02/10/2009 | CA2288601C Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| 02/10/2009 | CA2198743C Feline infectious peritonitis vaccine |
| 02/05/2009 | WO2009018465A1 Vaccination with killed but metabolically active (kbma) protozoans with toll-like receptor agonists |
| 02/05/2009 | WO2009018441A1 Anti-cd28 antibodies for prolonging graft survival and treating type 1 diabetes |
| 02/05/2009 | WO2009018431A2 Novel synthetic agonists of tlr9 |
| 02/05/2009 | WO2009018429A2 TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-α2 |
| 02/05/2009 | WO2009018411A1 Human antibodies to human cd20 and method of using thereof |
| 02/05/2009 | WO2009018238A1 Combinations of mek inhibitors and raf kinase inhibitors and uses thereof |
| 02/05/2009 | WO2009018152A1 Uses of trientine and penicillamine as countermeasures to metal contamination |
| 02/05/2009 | WO2009018122A2 Methods and compositions for increasing alpha-iduronidase activity in the cns |